Two groups of 20 patients with no evidence of cardiovascular, hepatic, renal or gastrointestinal failure were treated orally for five days with placebo or SB 7505 100 mg/day. No change was observed in heart rate or blood pressure. Urine output, the excretion of Na, K and Cl, and creatinine clearance were significantly increased.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF00561945 | DOI Listing |
Publication Analysis
Top Keywords
renal 7505
4
7505 double-blind
4
double-blind study
4
study groups
4
groups patients
4
patients evidence
4
evidence cardiovascular
4
cardiovascular hepatic
4
hepatic renal
4
renal gastrointestinal
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!